CompletedNCT01354353
This study exists to better understand the safety of the medication Safety and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Safety in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT01452919
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Greece, United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT03873337
This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Rutgers, The State University of New Jersey
- Condition
- Schizophrenia
TerminatedNCT04140773
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Switzerland
- Sponsor
- Dragos Inta
- Condition
- Schizophrenia
TerminatedNCT01328093
This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand how people respond to the medication LY2140023 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Austria, Belgium, France, Germany, Poland, United States, Romania, Spain, Sweden
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT01052103
This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand whether the medication LY2140023 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Israel, Italy, Spain, United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT02504151
This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT03652974
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia
CompletedNCT03788759
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Brazil
- Sponsor
- Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
- Condition
- Schizophrenia
CompletedNCT03497013
This study exists to understand whether questionnaires and follow-up reports is both safe enough and useful enough to take further. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- China
- Sponsor
- Suzhou Psychiatric Hospital
- Condition
- Schizophrenia
CompletedNCT02686697
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Abraham Reichenberg
- Condition
- Schizophrenia
CompletedNCT02887794
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
CompletedNCT02976077
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- France
- Sponsor
- Hôpital le Vinatier
- Condition
- Schizophrenia
CompletedNCT03872310
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 55 Years
- Countries
- Taiwan
- Sponsor
- Taipei Medical University Shuang Ho Hospital
- Condition
- Schizophrenia
CompletedNCT05342727
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Iran
- Sponsor
- The National Brain Mapping Laboratory (NBML)
- Condition
- Schizophrenia
CompletedNCT02678858
This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- Heinrich-Heine University, Duesseldorf
- Condition
- Schizophrenia
TerminatedNCT03340909
This study exists to understand how blood tests and biological markers holds up over time after the earliest research stage. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Norway
- Sponsor
- Haukeland University Hospital
- Condition
- Schizophrenia
CompletedNCT03985904
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- Spain
- Sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Condition
- Schizophrenia
CompletedNCT04024371
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 20 Years to 55 Years
- Countries
- Germany, Greece, Netherlands, Spain
- Sponsor
- Maastricht University
- Condition
- Schizophrenia
CompletedNCT03576976
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
TerminatedNCT02739347
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Baylor College of Medicine
- Condition
- Schizophrenia
SuspendedNCT02108899
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
CompletedNCT03007628
This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia
CompletedNCT03711500
This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
CompletedNCT01100775
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia